AVXL... | Biotech Message Board Posts

Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  33870 of 34533  at  8/5/2020 4:34:16 PM  by

libertyhound

The following message was updated on 8/5/2020 4:37:41 PM.

AVXL...

  Anavex receives TGA special access scheme approval for ANAVEX 2-73 16:16 AVXL Anavex Life Sciences Corp. announced that patients from the ANAVEX 2-73-003 phase 2a Alzheimer's disease trial will continue treatment with ANAVEX 2-73 via the Australian Government Department of Health - Therapeutic Goods Administration, or TGA, compassionate use Special Access Scheme following completion of over 5-years daily dosing of ANAVEX 2-73 and recommendation by their physicians. The TGA approved the Special Access Scheme Category B applications based on the safety profile of ANAVEX 2-73, as well as clinical evidence that ANAVEX 2-73 may benefit patients. Anavex will facilitate continued access to ANAVEX 2-73 through the Special Access Scheme at the physicians' request.

Read more at:
https://thefly.com/landingPageNews.php?id=3140364 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 154
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...